Cancer care in India is at a pivotal moment and Aster DM Healthcare is staking a clear claim in the fight. In a major announcement, the healthcare chain revealed a ₹120 crore investment to expand its oncology and radiation therapy network, with a focus on establishing linear accelerator (LINAC)-equipped centers in strategic locations across India.

Radiation therapy particularly when delivered via linear accelerators is a cornerstone of modern cancer treatment. LINAC machines deliver highly focused, high-energy X-rays to target tumors while sparing surrounding healthy tissue. The technology is critical for treating a wide range of cancers, from head and neck to breast, lung, and more.

With this investment, Aster aims to broaden access to this advanced therapy well beyond traditional cancer hubs in major metros. Patients from Tier-2 and Tier-3 cities often travel long distances just to receive radiation treatment adding financial, physical, and emotional strain. By expanding LINAC centers in regional locations, Aster is trying to bring precision care closer to home.

The plan also emphasises multidisciplinary oncology care. Modern cancer treatment isn’t just about radiation  it’s about coordinated teams of medical oncologists, surgeons, radiologists, pathologists, and supportive care specialists working together. The new centers are designed to house this broad ecosystem, enabling seamless care pathways from diagnosis to treatment and follow-up.

Beyond hardware, the investment will fund specialist training, quality assurance programs, and patient-centric services that support treatment adherence, symptom management, and survivorship care. Aster’s leadership says this stepped-up focus addresses both capacity gaps and quality disparities two major challenges in India’s cancer care landscape.